Press What’s news at AbelsonTaylor Group
Select category
What pharma marketers should know about Bluesky
In the ever-changing world of social media, Bluesky has emerged as an intriguing new platform, particularly for HCPs and the broader pharma industry. As a decentralized, ad-free network, it offers a unique environment compared to other mainstream social platforms. In a featured article in MedAdNews, Helen Hoye, associate director of engagement strategy at AbelsonTaylor Group, shares some key things for pharma marketer to know about Bluesky.
Read more: https://www.pharmalive.com/what-pharma-marketers-should-know-about-bluesky/
Media Contact:
Recent Posts
From Insights to Action: The Bridge Between Strategy and Execution
“Having access to more information doesn’t automatically lead to better decisions—you need judgment,” says AbelsonTaylor Group’s Amy Restko, VP, Engagement...
In the News Read more From Insights to Action: The Bridge Between Strategy and ExecutionRob Chartier Joins AbelsonTaylor Group as Director of Engagement Strategy
AbelsonTaylor Group today announced that Rob Chartier has joined the agency as Director of Engagement Strategy. Chartier brings more than...
Read Press Read more Rob Chartier Joins AbelsonTaylor Group as Director of Engagement StrategyThe Human Story Underneath the Data: Translating Clinical Rigor into Brand Strategy
In an interivew with Roastbrief US, Planning Director Elise Pietracatella explains how at AbelsonTaylor Group believes the science and the...
In the News Read more The Human Story Underneath the Data: Translating Clinical Rigor into Brand StrategyConnect with us
Find out what's top of mind for the people reimagining health and wellness advertising.